Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
批准号:
10155409
负责人:
Guoquan Zhang
金额:
$21.34万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-01 至 2024-04-30
关键词:
AcuteAerosolsAmerican soldierAnti-Inflammatory AgentsAntibodiesAustraliaB-LymphocytesBiological WarfareCategoriesCellsCellular ImmunityChronicChronic DiseaseCoxiella burnetiiDangerousnessDevelopmentDiagnosisDiseaseDisease OutbreaksEnvironmental Risk FactorErythemaExposure toFormalinGoalsGram-Negative BacteriaHeadacheHealthHomeHost DefenseHumanHypersensitivity skin testingImmune responseImmunityImmunologicsImmunotherapeutic agentImmunotherapyIndividualInfectionInflammatory ResponseKnowledgeLeadLife StyleMediatingMiddle EastMonitorMusNatureNetherlandsOrganismOutcomePhagocytesPhasePlayPreventionPrevention strategyProductionPublic HealthQ FeverReportingResearchResistanceRoleSerologySoldierSpleenSplenomegalySwellingSymptomsT-LymphocyteTestingTherapeuticUltraviolet RaysVaccinatedVaccinationVaccinesWhole Cell VaccineWorkZoonosesaerosolizedbiosecuritybioterrorism/chemical warfarecytokinefluhigh riskimmunoprophylaxisinnovationmouse modelnovelnovel strategiespathogenpathogenic bacteriaprophylacticseropositiveside effectskin vaccinationweapons
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Q fever is a worldwide zoonotic disease that is caused by the obligate intracellular Gram-negative bacterium,
Coxiella burnetii. Human Q fever can develop into a severe chronic, potentially fatal disease. Although this
organism previously weaponized and currently classified as a category B select agent, no vaccine is
commercially available for the prevention of human Q fever in the US. Therefore, the development of safe and
effective prophylactic and therapeutic strategies for controlling C. burnetii infection remains an important goal
for public health and national biosecurity. However, there is a fundamental gap in the knowledge regarding the
mechanisms of host immune response to C. burnetii natural infection. To fill this gap, this new R21 application
aims to explore whether B1 B cells play a critical role in controlling bacterial replication and regulating host
immune response during C. burentii aerosol infection. Despite C. burnetii being an intracellular bacterial
pathogen, our preliminary study demonstrates that a C. burnetii infection induces more severe splenomegaly
and higher bacterial burden in the spleens of B1 cell deficient mice, suggesting that B1 cells play an important
role in host defense against primary C. burnetii infection. The objective of this application is to use a C. burnetii
aerosol infection mouse model to determine the mechanisms of B1 cell-mediated protective immunity against
C. burnetii natural infection. To achieve this objective, two specific aims were proposed to test the central
hypothesis that B1 cell-mediated protective immunity against C. burnetii infection depends on its abilities to
control bacterial replication and regulate inflammatory response. Aim 1 will determine if B1 cells can mediate
killing of C. burnetii. We will determine whether i) B1 cells play a critical role in host defense against C. burnetii
aerosol infection; and ii) B1 cells can function as phagocytes to mediate clearance of C. burnetii. Aim 2 will
determine if B1 cells can regulate C. burnetii infection-induced inflammatory responses. We will determine i)
whether B1 cells are crucial for regulating aerosolized C. burnetii-induced inflammatory response; and ii) how
B1 cells regulate inflammatory response during C. burnetii infection. As an outcome of the proposed research,
we expect to enhance our understanding of the mechanisms of B1 cell-mediated protective immunity against
C. burnetii natural infection. This will have significant positive effects on human health, because it will provide
critical information for developing novel immunotherapeutic strategies against Q fever.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII
-
批准号:10020119
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2019
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:10207396
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:10005679
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Use of a Humanized Antibody against Intracellular Bacterial Pathogen
-
批准号:10003580
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:9982219
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER
-
批准号:10049108
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:9762833
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8582500
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8386914
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8197349
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8042033
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
The Role of Antibody-Mediated Protective Immunity Against Q fever
-
批准号:7876866
-
项目类别:
-
资助金额:$18.01万
-
财政年份:2009
-
负责人:Guoquan Zhang
-
依托单位:
The Role of Antibody-Mediated Protective Immunity Against Q fever
-
批准号:7740026
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2009
-
负责人:Guoquan Zhang
-
依托单位:
海外基金